Miracle Drug, Broken System: The Flawed Global Rollout of Twice-Yearly Lenacapavir
This episode explores lenacapavir, a groundbreaking twice-yearly injectable drug promising to revolutionize HIV prevention. Despite exceptional clinical trial results in Uganda demonstrating near-total protection, the real-world rollout faces massive hurdles. We analyze the stark divide between cutting-edge medical innovation and systemic implementation failures. From supply chain bottlenecks and severe inventory shortages in high-risk communities to staggering list prices and devastating foreign aid cuts, this episode deconstructs how political, financial, and logistical barriers threaten to…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.